Partner Headlines - ALKS

  1. Stocks Up, Google At High; Dow Takes Out 14,000

    Investors Business Daily

  2. Regeneron, Other Biomed Stocks Rebound On New Drugs

    Investors Business Daily

  3. Alkermes

    Investors Business Daily

  4. Stocks Slip As Fed Stands Pat; SodaStream Trims Gain

    Investors Business Daily

  5. Alkermes Trades Tightly, Holds In Buying Range

    Investors Business Daily

  6. UPDATE: Credit Suisse Initiates Alkermes at Neutral; ...

    Benzinga

  7. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    Investors Business Daily

  8. Top 4 Stocks In The Drug Delivery Industry With The ...

    Benzinga

  9. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    Investors Business Daily

  10. Alkermes In Buy Area After Breakout In Strong Volume

    Investors Business Daily

  11. Stocks Pare Early Losses, End With Modest Declines

    Investors Business Daily

  12. Alkermes Announces Notice of Allowance of USPTO ...

    Benzinga

  13. Alkermes Announces Positive Results from Phase 1 Study ...

    Benzinga

  14. Biotech Alkermes Sketches Imperfect Cup With Handle

    Investors Business Daily

  15. Alkermes' Acquisition Proves To Be Game-Changer

    Investors Business Daily

  16. Alkermes' Corporate Presentation to be Webcast at Two ...

    Benzinga

  17. Dow Leads Market Higher As Volume Swells

    Investors Business Daily

  18. Stocks Add To Gains; DaVita HealthCare Jumps

    Investors Business Daily

  19. Alkermes Flies As Q2 Results, Guidance Beat Estimates

    Investors Business Daily

  20. Alkermes' Breakout Falls Victim To Market Correction

    Investors Business Daily

  21. Stocks Tumble On Disappointing Earnings Reports

    Investors Business Daily

  22. Why Cisco, Google And Apple All Became Big Winners

    Investors Business Daily

  23. Biotech Alkermes Attracting Flocks Of Top-Rated Funds

    Investors Business Daily

  24. Biogen, Cubist and Alexion Not The Only Biomed Leaders

    Investors Business Daily

  25. Alkermes In Buying Range Above Cup-Base Entry

    Investors Business Daily

  26. Alkermes Writes New Prescription For Growth

    Investors Business Daily

  27. Lennar, Other Homebuilders Crush Profit Estimates

    Investors Business Daily

  28. Health Care Sector Wrap

    FOXBusiness

  29. UPDATE: J.P. Morgan Lowers Alkermes' PT

    Benzinga

  30. UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers ...

    Benzinga

  31. Elan

    at IBD

  32. Alkermes plc Prices Secondary Offering of 21,000,000 ...

    at Benzinga

  33. Alkermes Announces a Secondary Offering of 13,900,000 ...

    at Benzinga

  34. Market Roundup

    at Benzinga

  35. Alkermes Inc. (ALKS) SVP & CFO, Alkermes plc James M ...

    at GuruFocus

  36. Alkermes Files Resale Shelf Registration in Connection ...

    at Benzinga

  37. Alkermes Inc. (ALKS) SVP, COO & CRO, Alkermes, Inc. ...

    at GuruFocus

  38. Alkermes Inc. (ALKS) SVP & CFO, Alkermes plc James M ...

    at GuruFocus

  39. Alkermes Inc. (ALKS) Director and CEO, Alkermes plc ...

    at GuruFocus

  40. Amylin Pharmaceuticals Continues to Soar in Wake of ...

    at Benzinga

  41. Benzinga's M&A Chatter for Monday January 30, 2012

    at Benzinga

  42. Benzinga's Top Pre-Market Gainers

    at Benzinga

  43. UPDATE: FDA Approves BYDUREON, for Type 2 Diabetes

    at Benzinga

  44. Alkermes Inc. (ALKS) SVP, COO & CRO, Alkermes, Inc. ...

    at GuruFocus

  45. Benzinga's Volume Gainers

    at Benzinga

  46. CORRECTION: Bydureon Drug Approval Undecided by FDA; ...

    at Benzinga

  47. Feuerstein: Alkermes CEO says Bydureon Drug will be ...

    at Benzinga

  48. Top-Performing Fund Managers Tap Retail, Food Stocks

    at IBD

  49. Positive Data Lifts Stocks in Early Trading

    At Market Intelligence Center

  50. Alkermes Inc. (ALKS) SVP & CFO, Alkermes plc James M ...

    at GuruFocus
Marketplace
Trading Center